Efficacy and Safety of Temporal Interference Stimulation on Cognitive Function in Patients With Early-Stage Alzheimer's Disease

Enrolling by invitation · Not applicable · Has a placebo group

Conditions studied: Alzheimer Disease

In brief

This study aims to investigate the efficacy and safety of a novel non-invasive brain stimulation technique-Temporal Interference Stimulation (TIS)-in patients with early-stage Alzheimer's disease. A total of 40 participants will be randomly assigned to either the TIS group or the sham stimulation group. The intervention will last for 2 weeks, with cognitive and safety assessments at baseline, post-treatment, and 12 weeks after treatment.

Key facts

Study ID
NCT07543094
Run by
Ruijin Hospital
People needed
40
Starts
2025-11-01
Expected to finish
2027-09-30
Last updated by the study team
2026-04-24

Who can join

Age: 50 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.